Targeting B7-H3 Immune Checkpoint With Chimeric Antigen Receptor-Engineered Natural Killer Cells Exhibits Potent Cytotoxicity Against Non-Small Cell Lung Cancer

Shuo Yang(University of Macau), Qi Zhao(University of Macau), Hang Fai Kwok(University of Macau), Guangyu Zhou(China Medical University), Lu Wang(Children's Hospital of Philadelphia), Li Zhang(Fourth Hospital of Changsha), Bihui Cao(Guangdong Academy of Medical Sciences), Zhenfeng Zhang(Dalian Medical University), Lipeng Zhu(Beijing Institute of Technology)
Frontiers in Pharmacology
July 30, 2020
10.3389/fphar.2020.01089
Cited by 80

Related Papers

The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer
|Cellular Physiology and Biochemistry|2017|4.1k
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)
|The Journal of Experimental Medicine|2000|582
Tocilizumab for Treatment of Mechanically Ventilated Patients With COVID-19
|Clinical Infectious Diseases|2020|501